» Articles » PMID: 32998120

Direct Extrusion of Individually Encapsulated Endothelial and Smooth Muscle Cells Mimicking Blood Vessel Structures and Vascular Native Cell Alignment

Overview
Journal Biofabrication
Date 2020 Sep 30
PMID 32998120
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Cardiovascular diseases (CVDs) are considered the principal cause of worldwide death, being atherosclerosis the main etiology. Up to now, the predominant treatment for CVDs has been bypass surgery from autologous source. However, due to previous harvest or the type of disease, this is not always an option. For this reason, tissue engineered blood vessels (TEBV) emerged as an alternative graft source for blood vessel replacement. In order to develop a TEBV, it should mimic the architecture of a native blood vessel encapsulating the specific vascular cells in their respective layers with native alignment, and with appropriate mechanical stability. Here, we propose the extrusion of two different cell encapsulating hydrogels, mainly alginate and collagen, and a sacrificial polymer, through a triple coaxial nozzle, which in contact with a crosslinking solution allows the formation of bilayered hollow fibers, mimicking the architecture of native blood vessels. Prior to extrusion, the innermost cell encapsulating hydrogel was loaded with human umbilical vein endothelial cells (HUVECs), whereas the outer hydrogel was loaded with human aortic smooth muscle cells (HASMCs). The size of the TEVB could be controlled by changing the injection speed, presenting homogeneity between the constructs. The obtained structures were robust, allowing its manipulation as well as the perfusion of liquids. Both cell types presented high rates of survival after the extrusion process as well as after 20 d in culture (over 90%). Additionally, a high percentage of HASMC and HUVEC were aligned perpendicular and parallel to the TEBV, respectively, in their own layers, resembling the physiological arrangement found. Our approach enables the rapid formation of TEBV-like structures presenting high cell viability and allowing proliferation and natural alignment of vascular cells.

Citing Articles

Innovative Atherosclerosis Models: Advancing Pathophysiology and Translational Research.

Jiang H, Liao Y, Zhu M, Jiramonai L, Wu H, Zhong Y Research (Wash D C). 2025; 8:0617.

PMID: 40046514 PMC: 11881979. DOI: 10.34133/research.0617.


Current Status of Bioprinting Using Polymer Hydrogels for the Production of Vascular Grafts.

Matejkova J, Kanokova D, Matejka R Gels. 2025; 11(1).

PMID: 39851975 PMC: 11765431. DOI: 10.3390/gels11010004.


Bioengineered human arterial equivalent and its applications from vascular graft to disease modeling.

Luo X, Pang Z, Li J, Anh M, Kim B, Gao G iScience. 2024; 27(11):111215.

PMID: 39555400 PMC: 11565542. DOI: 10.1016/j.isci.2024.111215.


Micro- and nano-fibers for organ-on-a-chip: Construction, applications, and prospects.

Yang X, Shi J, Shi B, Li J, Xue C, Ma J Mater Today Bio. 2024; 29:101322.

PMID: 39554843 PMC: 11567939. DOI: 10.1016/j.mtbio.2024.101322.


Harnessing the power of bioprinting for the development of next-generation models of thrombosis.

Liu Y, Huang T, Yap N, Lim K, Ju L Bioact Mater. 2024; 42:328-344.

PMID: 39295733 PMC: 11408160. DOI: 10.1016/j.bioactmat.2024.08.040.